title: Treatment of ankylosing spondylitis: focus on etanercept.
abstract: Ankylosing spondylitis is a chronic inflammatory condition which preferentially affects the axial skeleton, often beginning in the sacroiliac joints. The etiology of the pathologic lesions of this condition including enthesitis, erosive articular changes, osteitis, and fibrous ankylosis, as well as changes which occur in the eye, gastrointestinal tract, cardiovascular system, and lungs is unknown; however, there is a strong association with HLA-B27, which indicates altered immunity. One of the major mediators of the immune response is TNF-alpha, which functions as a pleiotrophic soluble messenger primarily from macrophages. TNF-alpha is principally involved with activation of both normal and transformed cells, including endothelium, synoviocytes, osteoclasts, chondrocytes, and fibroblasts. The cornerstone of medical management of ankylosing spondylitis includes intensive physical therapy and nonsteroidal anti-inflammatories for symptomatic relief. However, it is becoming increasingly recognized that TNF-alpha blockade has an important role in the reduction of spine and joint inflammation. This review discusses the data that supports use of etanercept in the treatment of ankylosing spondylitis.
authors.affiliation: University of Utah, Division of Rheumatology, UT, USA.
authors.forename: Tracy
authors.initials: T
authors.lastname: Frech
references.citation: Ann Rheum Dis. 2006 Sep;65(9):1184-7
references.pmid: 16414970
references.citation: Arthritis Rheum. 2001 Sep;44(9):2112-7
references.pmid: 11592375
references.citation: Best Pract Res Clin Rheumatol. 2006 Jun;20(3):401-17
references.pmid: 16777573
references.citation: Arthritis Rheum. 2003 Nov;48(11):3230-6
references.pmid: 14613288
references.citation: Ann Rheum Dis. 2004 Sep;63(9):1041-5
references.pmid: 15066864
references.citation: Arthritis Rheum. 2003 Nov;48(11):3013-22
references.pmid: 14613261
references.citation: J Intensive Care Med. 2004 Nov-Dec;19(6):320-34
references.pmid: 15523118
references.citation: Ann Rheum Dis. 2006 Apr;65(4):423-32
references.pmid: 16126792
references.citation: J Rheumatol. 1994 Oct;21(10):1883-7
references.pmid: 7837155
references.citation: Arthritis Rheum. 1999 Nov;42(11):2325-9
references.pmid: 10555027
references.citation: J Rheumatol. 1998 Apr;25(4):714-7
references.pmid: 9558174
references.citation: Ann Rheum Dis. 2003 May;62(5):455-9
references.pmid: 12695160
references.citation: Best Pract Res Clin Rheumatol. 2006 Aug;20(4):757-90
references.pmid: 16979537
references.citation: Curr Opin Rheumatol. 2001 Jul;13(4):265-72
references.pmid: 11555726
references.citation: J Neurosurg. 1993 Jun;78(6):871-8
references.pmid: 8487068
references.citation: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004524
references.pmid: 17054209
references.citation: J Rheumatol. 1995 Dec;22(12):2266-72
references.pmid: 8835560
references.citation: Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S158-61
references.pmid: 12463469
references.citation: Arthritis Rheum. 1994 Jul;37(7):1039-45
references.pmid: 8024613
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004800
references.pmid: 15846731
references.citation: J Med Microbiol. 2000 Apr;49(4):305-311
references.pmid: 10755623
references.citation: Arthritis Rheum. 2001 Dec;44(12):2862-9
references.pmid: 11762947
references.citation: Rheum Dis Clin North Am. 1998 Nov;24(4):785-813, ix-x
references.pmid: 9891711
references.citation: Mol Med Today. 2000 Jun;6(6):224-30
references.pmid: 10840380
references.citation: J Rheumatol. 2005 Oct;32(10):1899-906
references.pmid: 16206344
references.citation: Immunol Lett. 2007 Jan 15;108(1):27-33
references.pmid: 17129613
references.citation: Ophthalmology. 2006 Dec;113(12):2317-23
references.pmid: 16996615
references.citation: Arthritis Rheum. 1995 Apr;38(4):499-505
references.pmid: 7718003
references.citation: Arthritis Rheum. 1984 Apr;27(4):361-8
references.pmid: 6231933
references.citation: Cytokine. 2004 Nov 21-Dec 7;28(4-5):179-81
references.pmid: 15588693
references.citation: J Rheumatol. 2006 Nov;33(11):2167-72
references.pmid: 16981296
references.citation: Arthritis Rheum. 2006 Feb;54(2):569-78
references.pmid: 16447233
references.citation: Rheumatology (Oxford). 2005 Mar;44(3):342-8
references.pmid: 15561737
references.citation: Br J Rheumatol. 1994 Oct;33(10):927-31
references.pmid: 7921752
references.citation: Br J Rheumatol. 1997 Jul;36(7):766-71
references.pmid: 9255111
references.citation: Arthritis Rheum. 2005 Aug;52(8):2447-51
references.pmid: 16052578
references.citation: Arthritis Rheum. 1995 May;38(5):618-27
references.pmid: 7748217
references.citation: Ann Rheum Dis. 2005 Nov;64(11):1557-62
references.pmid: 15843448
references.citation: Ann Rheum Dis. 2004 Dec;63(12):1594-600
references.pmid: 15345498
references.citation: Curr Opin Pulm Med. 2006 Sep;12(5):342-5
references.pmid: 16926649
references.citation: Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii9-23
references.pmid: 12381507
references.citation: Curr Opin Rheumatol. 1998 Jul;10(4):314-8
references.pmid: 9725092
references.citation: J Rheumatol. 2006 Dec;33(12):2440-6
references.pmid: 17014005
references.citation: Drugs. 2004;64(24):2793-811
references.pmid: 15563249
references.citation: Ann Rheum Dis. 2006 Apr;65(4):442-52
references.pmid: 16126791
references.citation: Rheumatology (Oxford). 2007 Feb;46(2):327-34
references.pmid: 16880188
references.citation: N Engl J Med. 2002 May 2;346(18):1349-56
references.pmid: 11986408
references.citation: Med J Aust. 2005 Aug 15;183(4):205-8
references.pmid: 16097922
references.citation: J Rheumatol. 1997 Mar;24(3):507-10
references.pmid: 9058657